USFDA lifts import alert from Sun Pharma's Mohali plant

Mumbai: The import alert imposed on Sun Pharma's Mohali manufacturing facility by the US Food and Drug Administration (FDA) will be withdrawn and the facility will be removed f...

Pankaj Patel owned Cadila ups its India game with AZ's brands

Mumbai: Indian pharmaceutical major Zydus Healthcare has acquired brands in anti-infective and women’s health portfolio such as Bricarex, Bricarex-A, Bricanyl, Xylocard, Ceri...

Suven Life gets patent for neuro-degenerative drug

New Delhi: Suven Life Sciences, one of the leading bio-pharmaceutical firm in India, has been granted a patent by Australia for a drug used in the treatment of neuro-degenerative d...

Morgan Stanley PE Asia buys 20% in ZCL for Rs 170 crore

Mumbai: Morgan Stanley Private Equity Asia has invested Rs 170 crore (US$ 25 million) in ZCL Chemicals for a 20 per cent stake, which will help the chemicals company to fund its gr...

Sun Pharma acquires Novartis' oncology brand Odomzo for US$ 175 mn

Mumbai: Sun Pharmaceutical Industries Ltd, India's largest drug maker, has entered into an agreement with Switzerland-based Novartis AG, to acquire the latter’s branded c...

Cipla receives US FDA's approval for generic Tricor tablet

Mumbai: Pharmaceutical giant Cipla Ltd has received final approval from the US Food and Drugs Administration (FDA) for its abbreviated new drug application (ANDA) for fenofibrate t...

Cipla to set up manufacturing facility for pharmaceuticals in Iran

Mumbai: Indian multinational pharmaceutical company Cipla Limited has entered into an agreement with Ahran Tejarat Company to form a joint venture to set up a manufacturing facilit...

Glenmark launches first generic version of Zetia in US

Mumbai: Mumbai-based Glenmark Pharmaceuticals has launched the first and only generic version of Zetia (Merck) namely ezetimibe in US, by entering into a licensing partnership with...